Cost burden of breakthrough hemolysis in patients with...

Hematology/Oncology and Stem Cell Therapy 2020 / 01 Vol. 25; Iss. 1

Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab

Tomazos, Ioannis, Sierra, J. Rafael, Johnston, Karissa M., Cheung, Antoinette, Brodsky, Robert A., Weitz, Ilene C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Hematology
DOI:
10.1080/16078454.2020.1807226
Date:
January, 2020
File:
PDF, 1.14 MB
2020
Conversion to is in progress
Conversion to is failed